Nexplanon 68 MG implants

Ended Awarded Last action

Contract number
SPE2DR26FBQCH
Awardee
Awarding agency
Obligated
$12,967

Award facts

Contract value 100% obligated
$12,966.90 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on May 12, 2026, for $12,966.90 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to supply Nexplanon 68 mg implants.

DMS Pharmaceutical Group Inc. is a woman-owned small business headquartered in Park Ridge, Illinois, operating as the sole regional prime vendor under PPV-G GEN V's single-award indefinite delivery contract (SPE2DX) with a $499.999 billion ceiling extending through December 31, 2036. Place of performance is Park Ridge, IL. The delivery order is firm fixed-price with an ultimate completion date of June 3, 2026.

Quick answers

Who was awarded contract SPE2DR26FBQCH?

SPE2DR26FBQCH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 12, 2026.

How much is contract SPE2DR26FBQCH worth?

The government has obligated $12,967 on SPE2DR26FBQCH.

Is contract SPE2DR26FBQCH an order under another contract?

Yes. SPE2DR26FBQCH is a delivery order under SPE2DR25D9304, an indefinite delivery contract.

Was contract SPE2DR26FBQCH competed?

The extent of competition for SPE2DR26FBQCH was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award